Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy
Abstract Background Little was known on infection and mortality rates, still less the risk factors of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) omicron variant in B‐cell lymphoma patients following CD19 targeted chimeric antigen receptor T cell (CAR‐T). Aims We performed a retrosp...
| Հիմնական հեղինակներ: | , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Wiley
2023-11-01
|
| Շարք: | Cancer Medicine |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://doi.org/10.1002/cam4.6657 |